Inventor · Valencia, CA, US

Adrian Bot

20Patents
7h-index
23Co-inventors
69Inventor score

Filing activity: Nov 22, 1996 → Feb 20, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US6630169B1 Particulate delivery systems and methods of use Emerging Cross-Sectional Technologies 107 Expired
US9855298B2 Methods of conditioning patients for T cell therapy Chemistry; Metallurgy 29 Active
US6204250A Immunization of infants Emerging Cross-Sectional Technologies 21 Expired
US8703142B2 Methods to bypass CD4+ cells in the induction of an immune response Chemistry; Metallurgy 15 Active
US8653237B2 Peptide analogues Human Necessities 12 Active
US8354380B2 NY-ESO-1 peptide analogs Human Necessities 8 Active
US8084592B2 Multivalent entrain-and-amplify immunotherapeutics for carcinoma Human Necessities 8 Active
US7511119B2 PRAME peptide analogues Human Necessities 6 Active
US7141236B2 Methods and compositions for delivering macromolecules to or via the respiratory tract Human Necessities 5 Expired
US7511118B2 PSMA peptide analogues Human Necessities 4 Active
US10322146B2 Methods of conditioning patients for T cell therapy Chemistry; Metallurgy 4 Active
US7605227B2 Melanoma antigen peptide analogues Human Necessities 4 Active
US8809290B2 Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells Chemistry; Metallurgy 2 Active
US11779601B2 Diagnostic methods for T cell therapy Physics 1 Active
US11491187B2 Methods of conditioning patients for T cell therapy Chemistry; Metallurgy 1 Active
US8674081B2 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma Human Necessities 1 Active
US7999088B2 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma Human Necessities 1 Active
US12156887B2 Chimeric receptor T cell treatment using characteristics of the tumor microenvironment Physics 0 Active
US11357796B2 Treatment using chimeric receptor T cells incorporating optimized polyfunctional T cells Human Necessities 0 Active
US12252701B2 Chimeric antigen receptor T cell therapy Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.